Developer docs
API playgroundTry for free, no card

Search company profiles

Cloud-Clone

Full company profile

uuid00255vr

Namestring
Cloud-Clone
Legal namestring
CLOUD-CLONE CORP.(CCC)
Websiteurl
cloud-clone.com
Company typeenum
Private
Founded yearint
2009
Descriptiontext

Cloud-Clone Corp. (CCC) is a Wuhan, China-headquartered biotech company founded circa 2006–2009 that manufactures and globally distributes research reagents for the life sciences market. Its core product portfolio spans recombinant proteins, polyclonal/monoclonal/recombinant antibodies, ELISA kits (sandwich, competition, high-sensitive, wide-range, instant, mini), chemiluminescent immunoassay (CLIA) kits, multiplex assay kits (FLIA), and more than 560 primary cell types. The company has built two notable proprietary technology assets: a magnetic-bead flow cytometry-based multiplex immunoassay platform backed by over 7,000 in-house validated antibody pairs, and a proprietary antibody library exceeding 27,000 validated targets.

Cloud-Clone operates a dual business model combining high-volume catalog reagent sales with custom development services and a Contract Research Organization (CRO) subsidiary focused on preclinical brain disease research (stroke, Parkinson's disease, traumatic brain injury). It sells directly through its e-commerce website and through a global distributor network spanning the United States, United Kingdom, France, and Japan, with sales offices in Houston, Texas and Wuhan, China. Pricing is not publicly disclosed; customers contact sales for quotes and purchases are transacted on a pay-as-you-go basis for catalog products, with project-based pricing for CRO and custom services.

Cloud-Clone's products are cited in more than 42,000 SCI-indexed publications as of end-2025, including high-impact journals such as Cell, Nature Medicine, and Nature Communications, providing a strong validation and discovery channel for academic and pharmaceutical buyers. The customer base spans academic researchers, medical centers, and pharmaceutical enterprises, with no single anchor customer dominating revenue. The company is privately held with no public funding rounds disclosed and operates with a headcount in the 51–100 range.

Short descriptiontext

Cloud-Clone Corp. is a Wuhan-headquartered biotech that manufactures and globally distributes proteins, antibodies, ELISA/CLIA/multiplex assay kits, and primary cells to academic researchers and pharmaceutical enterprises, and provides preclinical CRO services for brain disease drug development.

Operating statusenum
Operating
Ownership categoryenum
Headcount rangeband
51–100
akta.pro rankint
HeadquartersKaty, United States
HQ citystring
Katy
HQ countrystring
United States
HQ regionstring
North America
Markets served

Serves global market

Offices2 records

Each record includes

City, Country, Type, Description, Source

Keyword5 values
recombinant proteins, monoclonal antibodies, ELISA assay kits, primary cell culture, preclinical CRO services
Industry4 codes
PRIMARYHLAGAIAI
Reagents, Chemicals & Assay Kits (Buffers, Antibodies, ELISA, Enzymes)
SECONDARYHLAGAAAB
Preclinical CROs (Discovery/Pharmacology/DMPK)
SECONDARYHLAGAAAL
Specialty Therapeutic-Area CROs (e.g., oncology/rare disease)
SECONDARYHLAAAMAL
Biomarker Assay & Reagent Development (LDT/IVD assay design, antibodies/standards/controls)
Healthcare & Life Sciences/Biotechnology & Biologics/Biomarkers and Companion Diagnostics
NAICS code3 codes
  • Research and Development in Biotechnology (except Nanobiotechnology)541714
  • Scientific Research and Development Services5417
  • In-Vitro Diagnostic Substance Manufacturing325413
SIC code2 codes
  • In Vitro & In Vivo Diagnostic Substances2835
  • Services-Commercial Physical & Biological Research8731
Product category
Life Science Research Reagents
Social media profiles1 record
GTM motion2 records

Each record includes

Type, Description, Source

Revenue model3 records
1Research Reagent Products
TypeOne Time License
Description

Sale of proteins, antibodies, ELISA kits, CLIA kits, and multiplex assay kits to research institutions and pharmaceutical companies globally. Products are sold directly through the company's website and through distributor networks.

cloud-clone.com
2Preclinical CRO Services
TypeProfessional Services
Description

Contract research organization services for pharmaceutical enterprises and research institutions, providing full-chain preclinical research solutions including project protocol design, animal model construction, multi-index detection, molecular mechanism exploration, and data analysis for brain disease drug development.

financialcontent.com
3Custom Product Development
TypeProfessional Services
Description

Customized service offerings for recombinant proteins, antibodies, ELISA kits, and CLIA kits based on specific customer requirements, as indicated by customization service offers on the website.

einpresswire.com
Marketing channels3 records

Each record includes

Title, Type, Stage, Description, Source

Distribution channels3 records

Each record includes

Title, Type, Scope, Target buyer, Description, Source

Cost components6 values
Personnel, Technology or R&D, Operations, Supply Chain, Marketing or Sales, Infrastructure
Pricing details1 tier
1Research reagent products including recombinant proteins, antibodies, and assay kits
ModelUnit PricingBilling cadencePay-as-you-go
Notes

No pricing is publicly listed on the website. Customers must contact sales for pricing information.

cloud-clone.com
GTM typeB2B
B2B
Offering typeHardware or Manufacturing
Hardware or Manufacturing
Core offering1 text field

Cloud-Clone manufactures and sells life science research reagents including recombinant proteins, antibodies (polyclonal, monoclonal, recombinant), ELISA kits, CLIA kits, multiplex assay kits, and primary cells to research institutions and pharmaceutical companies globally. The company also provides preclinical CRO services specialized in brain disease research (stroke, Parkinson's disease, traumatic brain injury), offering standardized animal models, multi-layer pharmacodynamic evaluation, and full-chain preclinical research solutions.

Differentiator
Functional benefit
Problem solved
Quantifiable outcome1 of 5 values shown
  • Reduces biomarker detection time from 3 days to approximately 2 hours
+4 more records
Product overview1 text field

Cloud-Clone Corp. is a biotech company offering a comprehensive portfolio of proteins, antibodies, and assay kits alongside CRO services. The core products include recombinant proteins, antibodies (polyclonal, monoclonal, and recombinant), ELISA kits, CLIA kits, and multiplex assay kits. The company has developed a proprietary antibody library exceeding 27,000 validated targets and offers over 560 types of primary cells. The company operates as both an ODM (Original Design Manufacturer) for assay reagents and analysis equipment, and as a CRO (Contract Research Organization) for animal experiments, particularly specializing in brain disease research including stroke, Parkinson's disease, and traumatic brain injury. Their product portfolio supports research across cytokines, signal transduction, CD & adhesion molecules, enzyme & kinase, apoptosis, tumor immunity, infection immunity, and various disease categories including neuro science, hepatology, and cardiovascular biology.

Scale indicator5 records

Each record includes

Type, Value, Description, Source

Partnership1 partner
Strategic tierCoreTypeChannel Partner/ Reseller/ Distributor
Description

Cloud-Clone maintains a global distributor network for their research reagents and products, with distribution across multiple countries including the United States, United Kingdom, France, and Japan. Distributors enable the company to reach research institutions and pharmaceutical companies worldwide.

Recent move5 records

Each record includes

Date, Type, Title, Description, Source

Expansion highlight5 records

Each record includes

Type, Description

Peers10 records
TypeBroad incumbent
Description

Largest life science tools provider with extensive antibody, protein, and assay reagent portfolio plus preclinical CRO services (via PPD acquisition). Comprehensive incumbent competing across all of Cloud-Clone's product and service categories.

TypeDirect peer
Description

China-based biotech offering recombinant proteins, antibodies, ELISA kits, and assay reagents with comparable catalog breadth. Closest direct peer in product portfolio and geographic origin, competing head-to-head on antibodies and recombinant proteins for research use.

TypeDirect peer
Description

Major antibody and reagent supplier (now part of Danaher) with extensive catalog comparable to Cloud-Clone's. Direct competitor in primary antibodies and ELISA kits, with overlapping customer base in academic and pharma research.

TypeDirect peer
Description

China-rooted life science tools provider offering recombinant proteins, antibodies, gene synthesis, and preclinical CRO services. Comparable business model combining catalog reagents with custom services, direct competitor particularly in Asia-Pacific markets.

TypeBroad incumbent
Description

Major life science tools incumbent operating Bio-Plex multiplex immunoassay platform that competes directly with Cloud-Clone's flow cytometry-based multiplex technology. Broad life science portfolio including clinical diagnostics, providing scale and instrument-anchored distribution advantage.

TypeBroad incumbent
Description

Founded the xMAP bead-based multiplex platform that Cloud-Clone's flow cytometry platform explicitly positions against. Now part of DiaSorin, providing established clinical and research presence in multiplexed biomarker detection.

TypeDirect peer
Description

Specializes in recombinant proteins and cytokines for life science research, directly comparable to Cloud-Clone's recombinant protein portfolio. Now part of Thermo Fisher, expanding distribution scale against regional players like Cloud-Clone.

TypeDirect peer
Description

China-based CRO offering preclinical research services across multiple therapeutic areas, with significantly larger scale. Comparable brain/CNS preclinical CRO footprint to Cloud-Clone's specialized CRO services; an aspirational scale benchmark.

TypeEmerging player
Description

China-based antibody and reagent provider with rapidly expanding catalog and global distribution. Direct competitor particularly in polyclonal/monoclonal antibodies, representing the rising cohort of Chinese reagent suppliers pressuring Cloud-Clone on price.

TypeDirect peer
Description

Global leader in proteins, antibodies, and ELISA kits through its R&D Systems brand, with a comparable catalog breadth and established multiplex assay platforms (Luminex-based). Direct competitor across nearly all of Cloud-Clone's core reagent categories.

Market position
Strengths5 records

Each record includes

Headline, Details, Source

Weaknesses5 records

Each record includes

Headline, Details, Source

Competitive moat5 records

Each record includes

Type, Details

Key risks5 records

Each record includes

Headline, Details, Source

Key highlights6 records

Each record includes

Headline, Details, Source

Customer concentration

Classification, Details

Named customers4 records

Each record includes

Name, Industry, Type, Use case, Source, UUID

Segment3 records

Each record includes

Title, Type, Primary, Description, Pain point addressed, Use case, Source

Ideal customer profile3 records

Each record includes

Profile, Firmographic size, Sales motion, Sales cycle length, Buying structure, Purchase trigger, Buyer persona, Geography, Industry vertical, Primary use case, Description, Pain points, Evidence proof points, Target buyer

Technology focused
Yes
API detail
Has APIbool
No

Docs URL, Description

AI maturity
App detail

Has app

Feature4 records

Each record includes

Title, Differentiator, Description, Source

Core technology
Revenue estimate
Valuation estimate
Number of profiles
No data
No data
Funding overview

Funding stage, Last funding date, Total funding USD

Funding rounds

Each record includes

Round, Amount USD, Date, Pre money valuation, Total investors, Investors, News

Investors

Each record includes

Name, Type, Date of entry, Rounds participated, Website

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Each record includes

Name, Acquisition type, Announced date, Completed date, Status, Website, News

Investment

Each record includes

Name, Round, Announced date, Lead investor, Website, News

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Cloud-Clone

Life Science Research Reagentscloud-clone.com

Cloud-Clone Corp. is a Wuhan-headquartered biotech that manufactures and globally distributes proteins, antibodies, ELISA/CLIA/multiplex assay kits, and primary cells to academic researchers and pharmaceutical enterprises, and provides preclinical CRO services for brain disease drug development.

What Cloud-Clone does

Cloud-Clone Corp. (CCC) is a Wuhan, China-headquartered biotech company founded circa 2006–2009 that manufactures and globally distributes research reagents for the life sciences market. Its core product portfolio spans recombinant proteins, polyclonal/monoclonal/recombinant antibodies, ELISA kits (sandwich, competition, high-sensitive, wide-range, instant, mini), chemiluminescent immunoassay (CLIA) kits, multiplex assay kits (FLIA), and more than 560 primary cell types. The company has built two notable proprietary technology assets: a magnetic-bead flow cytometry-based multiplex immunoassay platform backed by over 7,000 in-house validated antibody pairs, and a proprietary antibody library exceeding 27,000 validated targets.

Cloud-Clone operates a dual business model combining high-volume catalog reagent sales with custom development services and a Contract Research Organization (CRO) subsidiary focused on preclinical brain disease research (stroke, Parkinson's disease, traumatic brain injury). It sells directly through its e-commerce website and through a global distributor network spanning the United States, United Kingdom, France, and Japan, with sales offices in Houston, Texas and Wuhan, China. Pricing is not publicly disclosed; customers contact sales for quotes and purchases are transacted on a pay-as-you-go basis for catalog products, with project-based pricing for CRO and custom services.

Cloud-Clone's products are cited in more than 42,000 SCI-indexed publications as of end-2025, including high-impact journals such as Cell, Nature Medicine, and Nature Communications, providing a strong validation and discovery channel for academic and pharmaceutical buyers. The customer base spans academic researchers, medical centers, and pharmaceutical enterprises, with no single anchor customer dominating revenue. The company is privately held with no public funding rounds disclosed and operates with a headcount in the 51–100 range.

Cloud-Clone firmographics

Firmographics
Name
Cloud-Clone
Legal name
CLOUD-CLONE CORP.(CCC)
Website
https://cloud-clone.com
Company type
Private
Founded year
2009
Operating status
Operating
Headcount range
51–100 employees
Short description
Cloud-Clone Corp. is a Wuhan-headquartered biotech that manufactures and globally distributes proteins, antibodies, ELISA/CLIA/multiplex assay kits, and primary cells to academic researchers and pharmaceutical enterprises, and provides preclinical CRO services for brain disease drug development.
Ownership category
akta.pro rank

Cloud-Clone industry classification

Industry
Product category
Life Science Research Reagents
NAICS
Research and Development in Biotechnology (except Nanobiotechnology) (541714), Scientific Research and Development Services (5417), In-Vitro Diagnostic Substance Manufacturing (325413)
SIC
In Vitro & In Vivo Diagnostic Substances (2835), Services-Commercial Physical & Biological Research (8731)
akta.pro industry
PRIMARYHLAGAIAI
Reagents, Chemicals & Assay Kits (Buffers, Antibodies, ELISA, Enzymes)
SECONDARYHLAGAAAB
Preclinical CROs (Discovery/Pharmacology/DMPK)
SECONDARYHLAGAAAL
Specialty Therapeutic-Area CROs (e.g., oncology/rare disease)
SECONDARYHLAAAMAL
Biomarker Assay & Reagent Development (LDT/IVD assay design, antibodies/standards/controls)
Healthcare & Life Sciences/Biotechnology & Biologics/Biomarkers and Companion Diagnostics

Keywords

  • Recombinant proteins
  • Monoclonal antibodies
  • ELISA assay kits
  • Primary cell culture
  • Preclinical CRO services

Where Cloud-Clone is headquartered

Location

Headquarters

HQ city
Katy
HQ country
United States
HQ region
North America

Offices2 records

Markets served

Cloud-Clone business model

Business model
GTM type
B2B
Offering type
Hardware or Manufacturing
Cost components
Personnel, Technology or R&D, Operations, Supply Chain, Marketing or Sales, Infrastructure

Revenue model

  1. Research Reagent Products: Sale of proteins, antibodies, ELISA kits, CLIA kits, and multiplex assay kits to research institutions and pharmaceutical companies globally. Products are sold directly through the company's website and through distributor networks.
  2. Preclinical CRO Services: Contract research organization services for pharmaceutical enterprises and research institutions, providing full-chain preclinical research solutions including project protocol design, animal model construction, multi-index detection, molecular mechanism exploration, and data analysis for brain disease drug development.
  3. Custom Product Development: Customized service offerings for recombinant proteins, antibodies, ELISA kits, and CLIA kits based on specific customer requirements, as indicated by customization service offers on the website.

Pricing tiers

ModelBillingPrice
Unit PricingPay-as-you-goResearch reagent products including recombinant proteins, antibodies, and assay kits

Go-to-market motion2 records

Distribution channels3 records

Marketing channels3 records

Cloud-Clone product offering

Product offering

Core offering

Cloud-Clone manufactures and sells life science research reagents including recombinant proteins, antibodies (polyclonal, monoclonal, recombinant), ELISA kits, CLIA kits, multiplex assay kits, and primary cells to research institutions and pharmaceutical companies globally. The company also provides preclinical CRO services specialized in brain disease research (stroke, Parkinson's disease, traumatic brain injury), offering standardized animal models, multi-layer pharmacodynamic evaluation, and full-chain preclinical research solutions.

Product overview

Cloud-Clone Corp. is a biotech company offering a comprehensive portfolio of proteins, antibodies, and assay kits alongside CRO services. The core products include recombinant proteins, antibodies (polyclonal, monoclonal, and recombinant), ELISA kits, CLIA kits, and multiplex assay kits. The company has developed a proprietary antibody library exceeding 27,000 validated targets and offers over 560 types of primary cells. The company operates as both an ODM (Original Design Manufacturer) for assay reagents and analysis equipment, and as a CRO (Contract Research Organization) for animal experiments, particularly specializing in brain disease research including stroke, Parkinson's disease, and traumatic brain injury. Their product portfolio supports research across cytokines, signal transduction, CD & adhesion molecules, enzyme & kinase, apoptosis, tumor immunity, infection immunity, and various disease categories including neuro science, hepatology, and cardiovascular biology.

Differentiator

Problem solved

Functional benefit

Quantifiable outcome

  • Reduces biomarker detection time from 3 days to approximately 2 hours
  • +4 more outcomes

Companies that use Cloud-Clone

Customer profile

Named customers4 records

Segments3 records

Ideal customer profiles3 records

Cloud-Clone technology and API

Technology

Technology focussed Yes

API detail

Has API
No
API docs
API detail

Core technology

AI maturity

App detail

Feature4 records

Cloud-Clone partnerships and signals

Strategic signal

Partnerships

One partnership is on record.

  • Global Distributor NetworkcoreChannel Partner/ Reseller/ DistributorCloud-Clone maintains a global distributor network for their research reagents and products, with distribution across multiple countries including the United States, United Kingdom, France, and Japan. Distributors enable the company to reach research institutions and pharmaceutical companies worldwide.

Scale indicators5 records

Recent moves5 records

Expansion highlights5 records

Cloud-Clone competitors and assessment

Company assessment

Broad incumbents

  • Thermo Fisher Scientific: Largest life science tools provider with extensive antibody, protein, and assay reagent portfolio plus preclinical CRO services (via PPD acquisition). Comprehensive incumbent competing across all of Cloud-Clone's product and service categories.
  • Bio-Rad Laboratories: Major life science tools incumbent operating Bio-Plex multiplex immunoassay platform that competes directly with Cloud-Clone's flow cytometry-based multiplex technology. Broad life science portfolio including clinical diagnostics, providing scale and instrument-anchored distribution advantage.
  • Luminex (DiaSorin): Founded the xMAP bead-based multiplex platform that Cloud-Clone's flow cytometry platform explicitly positions against. Now part of DiaSorin, providing established clinical and research presence in multiplexed biomarker detection.

Direct peers

  • Sino Biological: China-based biotech offering recombinant proteins, antibodies, ELISA kits, and assay reagents with comparable catalog breadth. Closest direct peer in product portfolio and geographic origin, competing head-to-head on antibodies and recombinant proteins for research use.
  • Abcam (Danaher): Major antibody and reagent supplier (now part of Danaher) with extensive catalog comparable to Cloud-Clone's. Direct competitor in primary antibodies and ELISA kits, with overlapping customer base in academic and pharma research.
  • GenScript: China-rooted life science tools provider offering recombinant proteins, antibodies, gene synthesis, and preclinical CRO services. Comparable business model combining catalog reagents with custom services, direct competitor particularly in Asia-Pacific markets.
  • PeproTech (part of Thermo Fisher): Specializes in recombinant proteins and cytokines for life science research, directly comparable to Cloud-Clone's recombinant protein portfolio. Now part of Thermo Fisher, expanding distribution scale against regional players like Cloud-Clone.
  • Wuxi AppTec: China-based CRO offering preclinical research services across multiple therapeutic areas, with significantly larger scale. Comparable brain/CNS preclinical CRO footprint to Cloud-Clone's specialized CRO services; an aspirational scale benchmark.
  • Bio-Techne (R&D Systems): Global leader in proteins, antibodies, and ELISA kits through its R&D Systems brand, with a comparable catalog breadth and established multiplex assay platforms (Luminex-based). Direct competitor across nearly all of Cloud-Clone's core reagent categories.

Emerging players

  • ABclonal: China-based antibody and reagent provider with rapidly expanding catalog and global distribution. Direct competitor particularly in polyclonal/monoclonal antibodies, representing the rising cohort of Chinese reagent suppliers pressuring Cloud-Clone on price.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat5 records

Key risks5 records

Key highlights6 records

Customer concentration

Cloud-Clone social profiles

Digital presence

Cloud-Clone financial estimates

Financial estimate

Revenue estimate

Valuation estimate

Cloud-Clone leadership team

Management profile

Number of profiles

Cloud-Clone funding detail

Funding detail

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

Cloud-Clone M&A and investment

M&A and investment

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Cloud-Clone

What does Cloud-Clone do?

Cloud-Clone manufactures and sells life science research reagents including recombinant proteins, antibodies (polyclonal, monoclonal, recombinant), ELISA kits, CLIA kits, multiplex assay kits, and primary cells to research institutions and pharmaceutical companies globally. The company also provides preclinical CRO services specialized in brain disease research (stroke, Parkinson's disease, traumatic brain injury), offering standardized animal models, multi-layer pharmacodynamic evaluation, and full-chain preclinical research solutions.

Is Cloud-Clone a public or private company?

Cloud-Clone is a private company. It is classified as unknown and is currently operating.

When was Cloud-Clone founded?

Cloud-Clone was founded in 2009. It employs 51 to 100 people.

Where is Cloud-Clone based?

Cloud-Clone is headquartered in Katy, United States, in the North America region.

How does Cloud-Clone make money?

Three revenue lines are on record. Research Reagent Products are the primary driver. The others are preclinical CRO Services and custom Product Development.

Who are Cloud-Clone's main competitors?

Broad incumbents on record are Thermo Fisher Scientific, Bio-Rad Laboratories and Luminex (DiaSorin). Direct peers are Sino Biological, Abcam (Danaher), GenScript, PeproTech (part of Thermo Fisher), Wuxi AppTec and Bio-Techne (R&D Systems). ABclonal is listed as an emerging player.

Does Cloud-Clone have an API?

No public API is recorded for Cloud-Clone.

What industry is Cloud-Clone in?

Cloud-Clone's product category is Life Science Research Reagents. Its primary akta.pro industry code is HLAGAIAI, Reagents, Chemicals & Assay Kits (Buffers, Antibodies, ELISA, Enzymes), with a secondary code of HLAGAAAB, Preclinical CROs (Discovery/Pharmacology/DMPK). Its NAICS code is 541714 and its SIC code is 2835.

Unlock the full company data

50 free credits on sign-up, no credit card required.

Contact sales
Live signals
EIN PresswireCloud-Clone Launches Allergy Research Portfolio Ahead of Peak Rhinitis SeasonCloud-Clone Corp. launched a portfolio of reagents and pre-clinical services for allergic rhinitis research, targeting type-2 airway inflammatory disorders. The six-module toolset includes ELISA kits, multiplex assays, recombinant proteins, antibodies, animal-model services, and contract testing, supporting OVA-sensitized models and biomarker quantification.EIN PresswireCloud-Clone Launches Allergy Research Portfolio Ahead of Peak Rhinitis SeasonCloud-Clone Corp. launched a comprehensive portfolio of reagents and pre-clinical services for allergic rhinitis research, targeting type-2 airway inflammatory disorders. The portfolio includes ELISA kits, multiplex assays, recombinant proteins, antibodies, animal-model services, and contract testing, supporting OVA-sensitized models and biomarker quantification.EIN PresswireMarking World Diabetes Day: Cloud‑Clone Supports Full‑Chain Metabolic Research with Diabetic Animal Models & ReagentsCloud-Clone Corp. offers diabetic animal models and reagents for pre-clinical diabetes research, including STZ-induced models and ELISA kits. The company provides integrated workflows for mechanistic studies and drug screening, citing products in Nature and The Lancet.EIN PresswireMarking World Diabetes Day: Cloud‑Clone Supports Full‑Chain Metabolic Research with Diabetic Animal Models & ReagentsCloud-Clone Corp. offers diabetic animal models and reagents for pre-clinical diabetes research, including STZ-induced and diet-induced models. The company provides ELISA kits, antibodies, and custom services, citing IDF data that over 500 million adults live with diabetes. The integrated workflow supports drug-mechanism studies and publication-ready datasets.Business & FinancialCloud-Clone Catalogue Covers More Than 120 Canine Primary Cell Types Across 13 Organ SystemsCloud-Clone announced a canine primary-cell catalogue covering over 120 cell types across 13 organ systems, supplied with matched culture media and detection reagents. The products are isolated under ISO-certified workflows from SPF-grade animals, and the company reports demand from veterinary research and contract research organizations.EIN PresswireCloud-Clone Catalogue Covers More Than 120 Canine Primary Cell Types Across 13 Organ SystemsCloud-Clone announced a canine primary-cell catalogue covering over 120 cell types across 13 organ systems, supplied with matched culture media and detection reagents. The products are isolated under ISO-certified workflows from SPF-grade animals, addressing fragmented supply and quality-control issues in the market.Business & FinancialQuantification Of Small-Molecule Biomarkers For Bone Metabolism: Cloud-Clone Competitive ELISA Assay SystemCloud-Clone Corp introduced competitive ELISA kits for bone-metabolism small-molecule biomarkers, including hydroxyproline, vitamin D metabolites, and chondroitin sulfate. The 96-well high-throughput system targets serum, urine, bone homogenate, and synovial fluid, offering cost-effective screening for osteoporosis and osteoarthritis research.Business & FinancialActive Collagen Type IV Α1 (COL4A1): Detection, Research Applications And Cloud‐Clone ProductsCloud-Clone Corp released a product line of recombinant active Collagen Type IV α1 (COL4A1) protein for pre-clinical research. The protein is designed to preserve native triple-helix conformation and cell-binding bioactivity, with an EC50 of 0.05 μg/mL for binding to GP6. It is intended for studies in nephropathy, tumour metastasis, fibrosis, and vascular biology.Business & FinancialActive TGF‐Β1: Unlocking Opportunities For Fibrosis, Cancer & Immunology Cloud-Clone Detection & Product GuideCloud-Clone Corp describes its recombinant human TGF-β1 protein, which retains intact homodimer conformation for functional assays. The product supports research on fibrosis, cancer, and immunology, with bioactivity assays showing an ED50 of 0.1 μg/mL against HepG2 cells. It is intended for pre-clinical drug screening and mechanistic studies.Business & FinancialQuantification Of Small-Molecule Biomarkers For Cardiovascular Diseases: Cloud-Clone Competitive ELISA Assay SystemCloud-Clone developed a competitive ELISA kit portfolio for quantifying small-molecule cardiovascular biomarkers, including cAMP, ADMA, epinephrine, and others. The kits are designed for high-throughput analysis of animal serum, plasma, and tissue, supporting pre-clinical drug screening and mechanistic studies.